Rho

Publications and Whitepapers

A comprehensive searchable list of Rho’s publications, presentations, posters, and white papers

Rho’s clinical research experts are some of the most respected and well published in the pharmaceutical, biotech, and medical device clinical research industry. The following is a searchable list of publications, presentations, posters, and white papers from our team of innovative, critical-thinking employees.

E.g., 2019-06-17
E.g., 2019-06-17

Novel antiretroviral agents in HIV therapy

Reed C, Daar ES Current Infectious Disease Reports HGDS 12/31/2005 Publication

Hepatitis C virus infection and neurocognitive function

Soogoor M, Lynn H, Donfield S, Gomperts E, Bell T, and Daar E Neurology HGDS 12/31/2005 Publication

Profound loss of HCV-specific interferon-gamma secreting CD4+ T cells in HIV/HCV co-infected patients

Harcourt G, Gomperts E, Donfield S, Klenerman P Gut HGDS 12/31/2005 Publication

Genetic variation in the CCL18-CCL3-CCL4 chemokine gene cluster influences HIV type 1 transmission and AIDS disease progression

Modi WS, Lautenberger J, An P, Scott K, Goedert JJ, Kirk G, Buchbinder S, Phair J, Donfield S, O'Brien SJ, and Winkler C The American Journal of Human Genetics HGDS 12/31/2005 Publication

AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis

Gao X, Bashirova A, Iversen AK, Phair J, Goedert JJ, Buchbinder S, Hoots K, Vlahov D, Altfeld M, O'Brien SJ, Carrington M Nature Medicine HGDS 11/30/2005 Publication

Primary human immunodeficiency virus type 1 infection

Soogoor M, Daar ES HIV/AIDS Reports HGDS 12/31/2004 Publication

Dynamic programming of CD8+ T cell trafficking after live viral immunization

Liu L, Fuhlbrigge RC, Karibian K, Tian T, Kupper TS Immunity ADVN 12/31/2005 Publication

Confronting the emergence of drug-resistant HIV type 1: Impact of antiretroviral therapy on individual and population resistance

Daar ES, Richman DD AIDS Research and Human Retroviruses HGDS 12/31/2004 Publication